Randomized trial · people

Tesamorelin: no change in glucose control in type 2 diabetes

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In people with type 2 diabetes, 12 weeks of tesamorelin did not change insulin response or blood sugar control compared with placebo.

Kind
Randomized trial
Studied in
People
Number studied
53
Published
2017
Journal
PLoS One

What they tested

The team tested whether tesamorelin changes insulin sensitivity or blood sugar control in people with type 2 diabetes.

How the study was done

A randomized, placebo-controlled trial at several centers in 53 patients with type 2 diabetes, run for 12 weeks. Patients got placebo (a dummy treatment), 1 mg tesamorelin or 2 mg tesamorelin.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The main outcome was relative insulin response after drinking glucose. It did not differ significantly between the groups over 12 weeks. At week 12, fasting glucose, HbA1c (a measure of average blood sugar over the past few months) and overall diabetes control were also not significantly different, and changes to diabetes medicines were similar across groups. In the 2 mg arm, total cholesterol fell by 0.3±0.6 mmol/L and non-HDL cholesterol by 0.3±0.5 mmol/L from baseline, a significant drop compared with placebo (p<0.05), and no patient left the study because of losing diabetes control.

What it doesn’t show

The trial was small and lasted only 12 weeks, so it does not show longer-term effects on blood sugar. It included only people with type 2 diabetes.

The paper

Clemmons et al. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PLoS One. 2017.

The compound

More studies on Tesamorelin

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo